Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage

Neurological Research

Volumn 32, Issue 7, 2010, Pages 715-720

  Guo, Zongduo ^a   Sun, Xiaochuan ^a   He, Zhaohui ^a   Jiang, Yong ^b   Zhang, Xiaodong ^a   Zhang, John H ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cell death; early brain injury; Matrix metalloproteinase 9; subarachnoid hemorrhage

Indexed keywords

GELATINASE B; LAMININ; MATRIX METALLOPROTEINASE INHIBITOR; SB 3CT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BRAIN INJURY; BRAIN WATER; CISTERNA MAGNA; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NEUROLOGIC DISEASE; NICK END LABELING; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPRAGUE DAWLEY RAT; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING; ZYMOGRAPHY;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELL COUNT; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LAMININ; MALE; MATRIX METALLOPROTEINASE 9; NEURONS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 77955632657     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164109X12478302362491     Document Type: Article

References (28)

1. Cahill J, Calvert J, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2000; 26: 1341-1353
2. Schubert GA, Poli S, Schilling L, et al. Hypothermia reduces cytotoxic edema and metabolic alterations during the acute phase of massive SAH: A diffusion-weighted imaging and spectroscopy study in rats. J Neurotrauma 2008; 25: 841-852
3. Gu Z, Cui J, Brown S, et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005; 25: 6401-6408
4. Krüger A, Arlt MJ, Gerg M, et al. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 2005; 65: 3523-3526
5. Prunell GF, Mathiesen T, Diemer NH, et al. Experimental subarachnoid hemorrhage: Subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 2003; 52: 165-175
6. Yamaguchi M, Zhou C, Nanda A, et al. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke 2004; 35: 1750-1755
7. Lundblad C, Bentzer P. Effects of L-arginine on cerebral blood flow, microvascular permeability, number of perfused capillaries, and brain water content in the traumatized mouse brain. Microvasc Res 2007; 74: 1-8
8. Kawakita K, Ishikawa M, Nanda A, et al. Expression of matrix metalloproteinase-9 in thrombin-induced brain edema formation in rats. J Stroke Cerebrovasc Dis 2006; 15: 88-95
9. Guo M, Cox B, Mahale S, et al. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke. Neuroscience 2008; 151: 340-351
10. Sifringer M, Stefovska V, Zentner I, et al. The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol Dis 2007; 25: 526-535
11. Zhao BQ, Tejima E, Lo EH. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 2007; 38: 748-752
12. Kiaei M, Kipiani K, Calingasan NY, et al. Matrix metalloproteinase- 9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 2007; 205: 74-81
13. Fukuda S, Fini CA, Mabuchi T, et al. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 2004; 35: 998-1004
14. Zalewska T, Ziemka-Nalecz M, Sarnowska A. Transient forebrain ischemia modulates signal transduction from extracellular matrix in gerbil hippocampus. Brain Res 2003; 977: 62-69
15. Rosell A, Cuadrado E, Ortega-Aznar A, et al. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 2008; 39: 1121-1126
16. Miner JH. Laminins and their roles in mammals. Microsc Res Tech 2008; 71: 349-356
17. Colognato H, Ffrench-Constant C, Feltri ML. Human diseases reveal novel roles for neural laminins. Trends Neurosci 2005; 28: 480-486
18. Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004; 20: 255-284
19. Lee KJ, Jang YH, Lee H, et al. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition. Eur J Neurosci 2008; 27: 334-342
20. Kusaka G, Ishikawa M, Nanda A, et al. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004; 24: 916-925
21. Sen O, Caner H, Aydin MV, et al. The effect of mexiletine on the level of lipid peroxidation and apoptosis of endothelium following experimental subarachnoid hemorrhage. Neurol Res 2006; 28: 859-863
22. Cai J, Kang Z, Liu WW, et al. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett 2008; 441: 167-172
23. Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 2006; 28: 399-414
24. Zhou C, Yamaguchi M, Kusaka G, et al. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 2004; 24: 419-431
25. Iseda K, Ono S, Onoda K, et al. Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg 2007; 107: 128-135
26. Cahill J, Calvert JW, Marcantonio S, et al. p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage. Neurosurgery 2007; 60: 531-545
27. Brown S, Bernardo M, Li Z, et al. Potent and selective mechanismbased inhibition of gelatinases. J Am Chem Soc 2000; 122: 6799-6800
28. Opdenakker G, van den Steen PE, van Damme J. Gelatinase B: A tuner and amplifier of immune functions. Trends Immunol 2001; 22: 571-579